75 results
8-K
EX-99.2
LSTA
Lisata Therapeutics Inc
2 Nov 23
Lisata Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:10pm
COVID-19 pandemic on Lisata’s business, the safety and efficacy of Lisata’s product candidates, decisions of regulatory authorities and the timing
8-K
EX-99.2
LSTA
Lisata Therapeutics Inc
14 Aug 23
Lisata Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
4:08pm
, without limitation: the impact of the ongoing COVID-19 pandemic on Lisata’s business, the safety and efficacy of Lisata’s product candidates
8-K
EX-99.2
a840ti5m8xwmo
9 May 23
Lisata Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
EX-99.1
wo8xgu9ls70u yh1nvw4
9 May 23
Lisata Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:08pm
8-K
EX-99.2
xig1xud6gr7ae
30 Mar 23
Lisata Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.1
z7vlm2jmpe uip
30 Mar 23
Lisata Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.1
sw4jj6y
10 Nov 22
Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.2
lm85f4ff3sxo8
10 Nov 22
Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:10pm
8-K/A
EX-99.2
ud0sgxx
4 Oct 22
Other Events
4:42pm
8-K
9f4a8cqr1sck jk2r
22 Sep 22
Regulation FD Disclosure
4:02pm
8-K
EX-99.1
gfdjjgp1dottfs59
22 Sep 22
Regulation FD Disclosure
4:02pm
8-K
EX-99.1
kl0gi7sjh5
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-99.2
strffs47
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
425
k307wbdh7bsc tx2
15 Aug 22
Business combination disclosure
6:46am
8-K
EX-99.1
17vww bdib47
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm